1.Kotthaus J, Schade D, Töpker-Lehmann K, Beitz E, Clement B.. (2008) N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system., 16 (5):[PMID:18083522][10.1016/j.bmc.2007.11.066]
2.Martin NI, Woodward JJ, Winter MB, Marletta MA.. (2009) 4,4-Difluorinated analogues of l-arginine and N(G)-hydroxy-l-arginine as mechanistic probes for nitric oxide synthase., 19 (6):[PMID:19230661][10.1016/j.bmcl.2009.01.076]
3.PubChem BioAssay data set,
4.Zhang Q, Milliken P, Kulczynska A, Slawin AM, Gordon A, Kirkby NS, Webb DJ, Botting NP, Megson IL.. (2013) Development and characterization of glutamyl-protected N-hydroxyguanidines as reno-active nitric oxide donor drugs with therapeutic potential in acute renal failure., 56 (13):[PMID:23782349][10.1021/jm400146r]
5.Holden JK, Kang S, Hollingsworth SA, Li H, Lim N, Chen S, Huang H, Xue F, Tang W, Silverman RB, Poulos TL.. (2015) Structure-based design of bacterial nitric oxide synthase inhibitors., 58 (2):[PMID:25522110][10.1021/jm501723p]
6.Litty FA, Gudd J, Girreser U, Clement B, Schade D.. (2016) Design, Synthesis, and Bioactivation of O-Glycosylated Prodrugs of the Natural Nitric Oxide Precursor N(ω)-Hydroxy-l-arginine., 59 (17):[PMID:27548300][10.1021/acs.jmedchem.6b00810]
7.Borek B,Gajda T,Golebiowski A,Blaszczyk R. (2020) Boronic acid-based arginase inhibitors in cancer immunotherapy., 28 (18):[PMID:32828425][10.1016/j.bmc.2020.115658]
8.Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X.. (2021) If small molecules immunotherapy comes, can the prime be far behind?, 218 [PMID:33773287][10.1016/j.ejmech.2021.113356]